The roles of vitamin D and cathelicidin on type 1 diabetes susceptibility

in Endocrine Connections
View More View Less
  • 1 C Cristelo, INEB, Universidade do Porto Instituto de Investigação e Inovação em Saúde, Porto, Portugal
  • 2 A Machado, Universidade do Minho Centro de Engenharia Biológica, Braga, Portugal
  • 3 B Sarmento, INEB, Universidade do Porto Instituto de Investigação e Inovação em Saúde, Porto, Portugal
  • 4 F Gama, Departamento de Engenharia Biológica, Universidade do Minho Centro de Engenharia Biológica, Braga, Portugal

Correspondence: Francisco Gama, Email: fmgama@deb.uminho.pt

Type 1 diabetes has increasingly greater incidence and prevalence with no cure available. Vitamin D supplementation is well documented to reduce the risk of developing type 1 diabetes. Being involved in the modulation of cathelicidin expression, the question whether cathelicidin may be one of the underlying cause arises. Cathelicidin has been implicated in both the development and the protection against type 1 diabetes by mediating the interplay between the gut microbiome, the immune system and β cell function. While its potential on type 1 diabetes treatment seems high, the understanding of its effects is still limited. This review aims to contribute to a more comprehensive understanding of the potential of vitamin D and cathelicidin as adjuvants in type 1 diabetes therapy.

If the inline PDF is not rendering correctly, you can download the PDF file here.

 

     European Society of Endocrinology

     Society for Endocrinology

Sept 2018 onwards Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 264 264 149
PDF Downloads 275 275 150